VivoSense Inc.

VivoSense Inc. is a wearable sensor Contract Research Organization (CRO) specializing in digital health technology (DHT) for clinical trials. Founded 14+ years ago, the company provides end-to-end wearable sensor services across 20+ therapeutic areas, serving pharmaceutical sponsors, contract research organizations, and digital health innovators in 30+ countries. The company's core offering includes DHT strategy consultation, wearable device selection and vendor management, protocol development, data collection operationalization, data cleaning and analysis, and clinical validation. VivoSense operates a proprietary DHT platform designed for compliance and auditability in clinical trial environments. The platform enables collection and processing of high-volume, complex sensor data into structured, actionable insights. The company has deployed 70+ wearable sensors to date across diverse disease areas. Clinical operations and data science teams leverage decades of combined experience in digital health technology implementation and sensor data analytics. Recent regulatory engagement includes qualification discussions with the European Medicines Agency (EMA) regarding MEADOW-RETT-BR, a DHT-based measure of apnea events in Rett syndrome patients. Notable partnerships include Biogen, Roche, argenx, Mayo Clinic, and GSK. Services span three phases: study startup (DHT strategy and measure selection), study conduct (operationalization and data collection), and study closeout (data investigation and statistical validation).